James E. Flynn - Significant Ownership

Signature - Title
/s/ Jonathan Isler - Jonathan Isler, Attorney-in-Fact
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by James E. Flynn.

Significant Ownership of James E. Flynn

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
OMIC Singular Genomics Systems, Inc. Common Stock, par value $0.0001 per share 100% $20K -$4.97M 1K -99.6% Deerfield Mgmt IV, L.P. Feb 21, 2025
LRMR Larimar Therapeutics, Inc. Common Stock, par value $0.0001 per share 35.81% $82.5M 30.7M Deerfield Management Company, L.P. Jul 31, 2025
NUVL Nuvalent, Inc. Class A common stock, $0.0001 par value per share 27.59% $1.56B 23.6M Deerfield Management Company, L.P. Dec 31, 2024
PHGE BiomX Inc. Common Stock, par value $0.0001 per share 9.99% $11.4M 15.6M Deerfield Management Company, L.P. Feb 27, 2025
AFIB Acutus Medical, Inc. Common Stock, par value $0.001 per share 9.1% $233K -$179K 5.49M -43.4% James E. Flynn Jan 27, 2025
AHCO AdaptHealth Corp. Class A Common Stock 8.48% $214M 23.9M Deerfield Management Company, L.P. Sep 30, 2025
Lomond Therapeutics Holdings, Inc. Common Stock 8.36% 2.69M Deerfield Mgmt, L.P. Sep 30, 2025
SPRY ARS Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 7.75% $101M -$13.6M 7.61M -11.9% Deerfield Management Company, L.P. Jul 30, 2025
SVRA Savara Inc. Common Stock 6.74% $48.4M 13.6M Deerfield Mgmt, L.P. Oct 30, 2025
COGT Cogent Biosciences, Inc. Common Stock 6.49% $46.4M 9.05M Deerfield Mgmt, L.P. Jul 7, 2025
CERT Certara, Inc. Common Stock 6.29% $122M 10M Deerfield Mgmt, L.P. Nov 7, 2025
BBOT BridgeBio Oncology Therapeutics, Inc. Common Stock 6.17% $46.2M 4.89M Deerfield Management Company, L.P. Aug 11, 2025
BCRX BioCryst Pharmaceuticals, Inc. Common Stock 5.8% $103M 12.2M Deerfield Mgmt, L.P. Sep 12, 2025
VERA Vera Therapeutics, Inc. Common Stock 5.25% $75.3M 3.35M Deerfield Mgmt, L.P. Jun 6, 2025
INSP Inspire Medical Systems, Inc. Common Stock 5.08% $110M 1.48M Deerfield Mgmt, L.P. Nov 6, 2025
CGEM Cullinan Therapeutics, Inc. Common Stock 4.95% $17.4M 2.93M Deerfield Mgmt, L.P. Sep 30, 2025
DCGO DocGo Inc. Common Stock 4.95% $13.3M 5.05M Deerfield Mgmt, L.P. Feb 13, 2025
BKD Brookdale Senior Living Inc. Common Stock 4.9% $85.4M -$27.3M 11.6M -24.2% Deerfield Mgmt, L.P. Aug 22, 2025
EMBC Embecta Corp. Common Stock 4.66% $33.5M 2.72M Deerfield Mgmt, L.P. Mar 31, 2025
MNKTQ Mallinckrodt plc Ordinary Shares, par value $0.01 per share 4.07% 804K Deerfield Management Company, L.P. Mar 31, 2025
ALHC Alignment Healthcare, Inc. Common Stock 3.81% $144M 7.3M Deerfield Mgmt, L.P. Dec 31, 2024
INDV Indivior PLC Ordinary Shares, $0.50 nominal value per share 3.7% $111M -$144M 4.61M -56.3% Deerfield Mgmt, L.P. Nov 10, 2025
CPRX Catalyst Pharmaceuticals, Inc. Common Stock 2.63% $76M 3.13M Deerfield Mgmt, L.P. Dec 31, 2024
VTYX Ventyx Biosciences, Inc. Common Stock 0.76% $503K 535K Deerfield Mgmt, L.P. Dec 31, 2024
OMI Owens & Minor, Inc. Common Stock 0% $0 0 Deerfield Mgmt, L.P. Mar 31, 2025
OSCR Oscar Health, Inc. Class A Common Stock 0% $0 0 Deerfield Mgmt, L.P. Sep 30, 2025
KURA Kura Oncology, Inc. Common Stock 0% $0 0 Deerfield Mgmt, L.P. Dec 31, 2024
PRLD Prelude Therapeutics Incorporated Common Stock 0% $0 0 Deerfield Mgmt, L.P. Dec 31, 2024

Schedules 13D/G Reported by James E. Flynn:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.